ELV
ELV
ELV
ELV NASDAQ
Beaconlight Capital LLC has established a new position in Elevance Health, Inc. ($ELV), according to defenseworld.net. This move comes as the company reports a full-year revenue of $199,125,000,000 and a market capitalization of $88,374,235,675. The stock currently trades at a PE ratio of 18.11, backed by a TTM EPS of 22.78 and a free cash flow yield of 7.12%.
Based on defenseworld.netBeaconlight Capital LLC Takes Position in Elevance Health, Inc. $ELV
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
Is ELV Undervalued? DCF Says Worth $614
Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV
31,408 Shares in Elevance Health, Inc. $ELV Acquired by B. Metzler seel. Sohn & Co. AG
Asahi Life Asset Management CO. LTD. Buys Shares of 1,279 Elevance Health, Inc. $ELV
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.